No Prescription |
 |
 | ||
|
Flomex Flarex |
|
| ||
No Prescription » Prescription Drugs 7 » Flomex Flarex This medication is used to treat eye conditions (e.g. conjunctivitis). It belongs to a class of drugs known as corticosteroids. Fluorometholone works by relieving swelling and itching.How to use Fluorometholone OphtTo apply eye drops wash your hands first. To avoid contamination do not touch the dropper tip or let it touch your eye or any other surface.If you are wearing contact lenses remove them before using eye drops. Wait at least 15 minutes before replacing your contact lenses.Shake this medicine well before using. Tilt your head back look upward and pull down the lower eyelid to make a pouch. Hold the dropper directly over your eye and place 1 drop into the pouch. Look downward and gently close your eyes for 1 to 2 minutes. Place one finger at the corner of your eye (near the nose) and apply gentle pressure. This will prevent the medication from draining out. Try not to blink and do not rub your eye. Repeat these steps for your other eye if so directed or if your dose is for more than 1 drop.Do not rinse the dropper. Replace the dropper cap after each use.If you are using another kind of eye medication (e.g. drops or ointments) wait at least 5 to 10 minutes before applying other medications. Use eye drops before eye ointments to allow the drops to enter the eye.Use as often as directed by your doctor usually 2 to 4 times a day. However your doctor may Online you to use the drops more often for the first 48 hours of treatment. Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same times each day.Continue using it for the full time prescribed. Do not stop using this medication without consulting your doctor. Some conditions may become worse when the drug is suddenly stopped. Your dose may need to be gradually decreased.Tell your doctor if your condition persists or worsens after 48 hours.Fluorometholone Opht is used to treat the following:Infection of the Cornea of the Eye due to Herpes Zoster Inflammation of the Iris - the Colored Part of the Eyeball Inflammation of the Uvea of the Eye Inflammation of the Iris and Ciliary Body of the Eye Inflammation of the Ciliary Body of the Eye Ulcer of the Cornea of the Eye Dotted Lesions or Damage on Cornea of Eye Allergic Conjunctivitis Inflammation of the Eye Inflammation of the Eye Following Surgery Severe Inflammation of the Cornea with Rosacea Involvement Scratch Wound on Cornea Buy Flomex Flarex and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Flomex Flarex: Product Type: Prescription Drugs 7 Flomex ( Flarex Generic Fluoromethalone ) Flomex (Flarex Generic Fluoromethalone) Flarex Generic Fluoromethalone 0.10% w/v 5mL Eye Drops 2 x 5mL Eye Drops 4 x 5mL Eye Drops Flarex Generic Fluoromethalone Flomex
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
